Oscar Health director granted 1,461 deferred units

Plouffe David reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Plouffe David reported acquisition or exercise transactions in this Form 4 filing.

Oscar Health, Inc. director David Plouffe received a grant of 1,461 deferred stock units as board compensation, based on the Class A common stock closing price of $14.54 on April 9, 2026. Each unit represents one share and is 100% vested on the grant date. Following this award, he holds 6,854 deferred stock units directly. These units will be settled in cash or shares, at the company’s discretion, within 45 days after termination of service, a change in control, death, or disability.

Insider Trade Summary

Grant/Award: 1,461 shares

Grant/Award 1 txn

Insider Plouffe David

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Unit	1,461	$14.54	$21K

Holdings After Transaction: Deferred Stock Unit — 6,854 contracts (Direct)

Footnotes (3)

F1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.
F2. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.
F3. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on April 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Key Figures

Deferred stock units granted: 1,461 units Reference share price: $14.54 per share Total deferred stock units after grant: 6,854 units +2 more

5 metrics

Deferred stock units granted 1,461 units Grant to director David Plouffe on April 9, 2026

Reference share price $14.54 per share Closing price of Class A common stock on April 9, 2026

Total deferred stock units after grant 6,854 units Director David Plouffe’s direct holdings following the award

Unit-to-share ratio 1 unit = 1 share Each deferred stock unit represents one Class A common share

Settlement window Within 45 days After termination, change in control, death, or disability

Key Terms

Deferred Stock Unit, Amended and Restated Deferred Compensation Plan for Directors, change in control

3 terms

Deferred Stock Unit financial

"Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock."

A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.

Amended and Restated Deferred Compensation Plan for Directors financial

"The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash"

change in control financial

"within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Oscar Health (OSCR) report for David Plouffe?

Oscar Health reported that director David Plouffe received 1,461 deferred stock units as board compensation. The award is fully vested on the grant date and is tied to the Class A common stock closing price on April 9, 2026.

How many Oscar Health (OSCR) deferred stock units does David Plouffe hold after this transaction?

After this transaction, David Plouffe holds 6,854 deferred stock units directly. Each unit represents the right to receive one share of Oscar Health Class A common stock, providing equity-based compensation for his service on the board of directors.

What is a deferred stock unit in the Oscar Health (OSCR) plan?

A deferred stock unit represents a right to receive one share of Oscar Health Class A common stock. These units are typically issued as non-cash compensation to directors and are settled later in cash or shares, depending on the company’s election under the plan.

When are David Plouffe’s Oscar Health (OSCR) deferred stock units settled?

The deferred stock units will be settled within 45 days after the earliest of termination of service, a change in control, death, or disability. Settlement can be in cash or Oscar Health Class A common shares, at the company’s discretion under the plan.

Why did David Plouffe receive deferred stock units instead of cash from Oscar Health (OSCR)?

David Plouffe elected to receive deferred stock units in lieu of cash retainer payments for his board service. This election was made under Oscar Health’s Amended and Restated Deferred Compensation Plan for Directors, aligning a portion of his compensation with the company’s equity.

How was the number of Oscar Health (OSCR) deferred stock units for David Plouffe calculated?

The 1,461 deferred stock units were calculated using the closing price of Oscar Health Class A common stock of $14.54 on April 9, 2026. That closing price determined how many units he received instead of a cash retainer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/13/2026 - 04:15 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plouffe David

(Last)

(First)

(Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK

10013

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Unit	⁽¹⁾	04/09/2026		A		1,461		⁽²⁾	⁽²⁾	Class A Common Stock	1,461	$14.54⁽³⁾	6,854	D

Explanation of Responses:

1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.

2. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

3. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on April 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

Remarks:

	/s/ Melissa Curtin, Attorney-in-fact	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR